Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?
Susan O'Brien et al.
Which is the best combination therapy in relapsed and refractory multiple myeloma?
A follow-up from the CASTOR trial evaluating daratumumab with bortezomib for the treatment of MM
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel
New therapies shaping the future of amyloidosis